ArticleCancers2025
OTC-NET: A Multimodal Method for Accurate Diagnosis of Ovarian Cancer in O-RADS Category 4 Masses.
Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence in ovarian cancer: advancing in precision diagnosis and clinical management.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundOvarian cancer is the deadliest female reproductive malignancy. Accurate preoperative differentiation of benign and malignant ovarian masses is critical for appropriate treatment. O-RADS category 4 lesions present a wide range of malignant risk, challenging radiologists. Ultrasonic images are the primary focus of current deep learning models, with no consideration for clinical data.
methodsWe proposed OTC-NET, a model that uses multimodal data for classification, which combines ultrasound images and clinical information to improve the classification ability of O-RADS 4 ovarian masses.
resultsOTC-NET outperforms seven deep learning models and three radiologists of varying experience, with AUC significantly higher than junior (
conclusionsThese results indicate that OTC-NET provides superior diagnostic accuracy and has strong potential for clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.